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Background: The World Health Organization recommends African children receive two doses of measles
containing vaccine (MCV) through routine programs or supplemental immunization activities (SIA). Moreover,
children have an additional opportunity to receive MCV through outbreak response immunization (ORI) mass
campaigns in certain contexts. Here, we present the results of MCV coverage by dose estimated through surveys
conducted after outbreak response in diverse settings in Sub-Saharan Africa.
Methods: We included 24 household-based surveys conducted in six countries after a non-selective mass
vaccination campaign. In the majority (22/24), the survey sample was selected using probability proportional
to size cluster-based sampling. Others used Lot Quality Assurance Sampling.
Results: In total, data were collected on 60,895 children from 2005 to 2011. Routine coverage varied between
countries (>95% in Malawi and Kirundo province (Burundi) while <35% in N’Djamena (Chad) in 2005), within a
country and over time. SIA coverage was <75% in most settings. ORI coverage ranged from >95% in Malawi to
71.4% [95% CI: 68.9-73.8] in N’Djamena (Chad) in 2005.
In five sites, >5% of children remained unvaccinated after several opportunities. Conversely, in Malawi and DRC,
over half of the children eligible for the last SIA received a third dose of MCV.
Conclusions: Control pre-elimination targets were still not reached, contributing to the occurrence of repeated
measles outbreak in the Sub-Saharan African countries reported here. Although children receiving a dose of MCV
through outbreak response benefit from the intervention, ensuring that programs effectively target hard to reach
children remains the cornerstone of measles control.
Keywords: Measles, Immunization, Expanded program of immunization, Supplemental, Immunization activity,
Outbreak response immunization, Vaccine coverageBackground
The World Health Organization (WHO) comprehensive
measles control strategy aims to reduce global measles
mortality by at least 95% by the end of 2015 compared
with 2000 estimates and achieve measles elimination in
at least five WHO regions by the end of 2020. One of the
components of the strategy is to achieve and maintain
high levels of population immunity by providing high vac-
cination coverage with two doses of measles-containing* Correspondence: lise.grout@hotmail.fr
1Epicentre, 8, rue St Sabin, 75011 Paris, France
Full list of author information is available at the end of the article
© 2014 Grout et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.vaccine (MCV) [1]. Children should receive the first MCV
dose through the Expanded Program of Immunization
(EPI). A second should be delivered either through
periodic supplemental immunization activities (SIAs)
or through EPI.
Moreover, since 2009, outbreak response immunization
(ORI) is part of WHO strategy for response to measles
outbreaks in measles mortality reduction settings [2]. If
assessment indicates the risk of a large outbreak, non-
selective reactive mass vaccination campaign should be
implemented as soon as the outbreak is confirmed. The
aim is to reduce morbidity and mortality in the immediatetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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children.
Although measles mortality was reduced by 91%
between 2001 and 2008 in the WHO African region
countries [3], measles remains a leading cause of vaccine-
preventable deaths in Africa [4]. Failure to deliver at least
one dose of MCV remains the primary reason for high
measles mortality.
In order to sustain gains in measles control and further
reduce mortality, an understanding of whether each of
these vaccination opportunities reaches children is
essential. Vaccination coverage is the key indicator to
measure the progress of measles control. Ministries of
Health (MoH) report annual administrative coverage
(i.e. number of doses delivered divided by estimated
number of children in the targeted age group) based
on population estimates. In many contexts, however,
population estimates, are often not up-to-date (i.e.
population censuses might not be frequently performed
and vital event registration may be absent or partial),
resulting in biased or inaccurate estimates. Consequently,
population-based surveys are often the best available
means to estimate vaccination coverage at both local
and national levels.
Over the past eight years, the non-governmental or-
ganization Médecins Sans Frontières (MSF) supported
MoH of several countries in sub-Saharan Africa in the
implementation of ORI through non-selective mass vac-
cination campaigns. Following these campaigns and as
part of the overall response to measles epidemics,
punctual household-based measles coverage surveys
were conducted [5-9]. The main objective of these sur-
veys was to estimate vaccination coverage through
ORI. These surveys also aimed to estimate measles
vaccine coverage through previous vaccination oppor-
tunities: in EPI, SIA, or outbreak response campaigns.
Here, we present a secondary data analysis of these
different surveys to describe measles vaccine coverage
through different vaccination opportunities in different
settings in sub-Saharan African countries. The aim is to
provide additional information on whether these different
vaccination opportunities reach children in need.
Methods
We considered all household-based measles vaccination
coverage surveys conducted by Epicentre after a non-
selective mass vaccination campaign that evaluated
different opportunities and for which the complete dataset
was available. We defined a survey as a unique analysis
of measles vaccination coverage. We considered a total
of 24 surveys conducted between 2005 and 2011 in 23
sites in 6 countries (Chad, Central African Republic
(CAR), Democratic Republic of Congo (DRC), Cameroon,
Malawi and Burundi). Surveys were conducted in differentlocations within a country in Chad, DRC, Malawi and CAR.
Two surveys were conducted at two different times in
N’Djaména (Chad). A total of 13 of the study sites were con-
sidered as urban or a mix of urban-rural (N’djamena city,
Matadi city, Mbuji-Mayi city, Blantyre, Lilongwe, Mzimba
and Balaka/Machinga districts, Likasi and Lubumbashi cities
and Kabo city), the others were considered as rural.
Design and settings of vaccine coverage studies
Surveys were conducted on average 30 days after the first
day of the mass vaccination campaign (range: 1 day to 4
months). The age group included in the surveys varied
according to the age group targeted by the ORI. All
surveys employed probability proportional to size cluster-
based sampling (Additional file 1: Table S1), except the
surveys conducted in N’Djamena (Chad) in 2005 and 2010
which used Lot Quality Assurance Sampling. The first
household to be surveyed in each cluster or lot was
selected randomly by spatial-based sampling [8], GPS-
based sampling, complete household enumeration or by
the EPI method [10]. Method for selection of the first
household was by preference by complete enumeration
when logistical and security constraints allowed. Subse-
quent households were selected by proximity. Sample size
varied according to the design and hypothesis about exist-
ing vaccination coverage (range: 942 to 6622 children).
Data collection
Trained surveyors conducted face-to-face interviews with
child’s main caregiver. Standardized, pre-piloted question-
naires were used and interviews were conducted in local
language(s). Information was collected on demographic
characteristics (age at the time of the survey or date of
birth, sex) and vaccination status for different vaccine
opportunities (Additional file 1: Table S1). When possible,
information on vaccination history was verified with
vaccination card. When card was not available, probing
questions, such as place were the vaccination took
place or injection site, were asked to minimize the risk
of misclassification.
Vaccination status was collected for different oppor-
tunities. ORI implemented by MoH with the support of
MSF (MSF/MoH ORI) and EPI were considered in all
study sites. Although different SIAs had been imple-
mented at different time points in these countries, only
vaccination during the most recent was considered.
Consequently, we considered SIA implemented in 2002
for the survey conducted in Mbuji-Mayi (DRC) in 2006;
SIA implemented in 2008 for the surveys conducted in
Malawi in 2010; and, SIA conducted in 2007 for the
surveys conducted in DRC in 2011. In Maroua (Cameroon)
and Kirundu (Burundi), SIAs were implemented before the
ORI but were not included in the surveys. Lastly, in four
countries (Cameroon, Malawi, Chad and CAR), we also
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conducted before MSF/MoH ORI.
Administrative coverage was provided by local health
authorities.
Data analysis
Children were considered as vaccinated through a specific
opportunity if they were eligible for vaccination (i.e. in the
target age group) and vaccination was reported by card
examination or oral history.
Vaccine coverage and 95% confidence interval (95% CI)
were estimated for each vaccine opportunity. EPI coverage
was defined as the proportion of children vaccinated
through the routine program among children aged 9 to
11 months (i.e. in the targeted window for this program)
and 12 to 23 months (i. e. who should have recently
received their MCV through EPI). SIA, ORI and other
potential MoH reactive campaigns coverage were defined
as the proportion of children vaccinated amongst the
target age group at the time of the campaign. ORI
coverage was calculated by age group.
If the delay between the last day of the MoH/MSF
campaign and the first day of the vaccine coverage survey
was <31 days, age at the time of the survey was considered
to be similar to age at the time of the MoH/MSF cam-
paign. If not, age at the first day of the MoH/MSF
campaign was calculated.
To evaluate if children received the two recommended
doses, we calculated the number of doses received by
summing the number of occasions a child was consid-
ered vaccinated. Only children with all information on
vaccine opportunities were included in this sub-analysis,
otherwise number of doses was considered as missing. In
Malawi and DRC, where EPI, SIA and ORI opportunities
were evaluated, we estimated the proportion of children
vaccinated through ORI according to the number of
doses of MCV they received before, and the proportion
of children for whom the ORI dose represent a first, a
second or a third dose of MCV. For this sub-analysis,
information on EPI vaccination was considered for all
children aged 9 month or older included in the survey
and not only for children 9 to 23 months of age.
To explore potential associations between vaccination
coverage and explanatory variables, Poisson regression
was conducted when several places were surveyed at the
same time. Wald tests were used to test explanatory vari-
ables (p < 0.05). Estimations were weighed to account for
survey designs. Data was entered in EpiData v3 (Odense,
Denmark) and analysed with Stata v11 (College Station,
Texas, USA).
Ethical considerations
Surveys were conducted as part of the monitoring and
evaluation of the emergency response and were notsubmitted for formal ethical approval in the country of
the study. The MSF Ethical Review Board exempts such
surveys from review as they constitute part of the emer-
gency response and use a standard and widely accepted
survey protocol. All studies, however, were approved by
local and national authorities through the convocation of
exceptional meetings. In N’Djamena, surveys were con-
ducted with the authorization of the national technical
committee for the battle against epidemics; in Matadi and
Mbuji Mayi (DRC), authorization was obtained from the
Ministry of Health; in Maroua (Cameroon), a request was
made to the Division of Operational Research within
the Ministry of Health for specific ethical clearance for
the survey and was granted; in Malawi, the study was
implemented in collaboration with the MoH after obtain-
ing permission to carry out the survey, in Katanga,
authorization was delivered by national and provincial
health authorities.
The main caregivers of all participants provided oral
informed consent via a specific explanation in the local
language as well as a written document providing infor-
mation on the use of information and on confidentially.
No specific ethnic or identifying information was recorded
and all participants were free to refuse participation in the
surveys. Vaccination and care were provided free of charge
irrespective of participation in surveys.
Results
Between 2005 and 2011 vaccination data was collected
from 60,895 children living in six countries. Half of them
were male (sex ratio = 1.0). Twelve of the surveys included
children 6 months to 14 years old, 5 surveys included chil-
dren 6 months to 4 years old and 1 considered children 6
months to 9 years old.
ORI coverage
Overall, MoH/MSF campaign coverage was >90% in
most surveys conducted in DRC (except Malemba-Nkulu,
Kambove and Kapolowe), Malawi (except Mzimba) and
Burundi (Table 1). Coverage was >95% in 3 districts of DRC,
including two urban districts (Likasi and Lubumbashi) and
one rural district (Kipushi). Coverage was also >95% in two
urban-rural districts of Malawi (Chiradzulu and Thiolo).
The lowest MoH/MSF campaign coverage was estimated
in N’Djaména (Chad) in the survey conducted in 2005
where less than 75% of children were vaccinated.
Estimated coverage varied within locations in Malawi
(p = 0.004) and in DRC in 2011 (p < 0.001), but not in
Moïssala district (Chad) (p = 0.07). In Malawi, the percent-
age of children vaccinated was highest in the rural area
of Chiradzulu and lowest in the urban-rural district of
Mzimba. In Katanga province (DRC), ORI 2011 cam-
paign coverage varied from 99.3% in the urban zone of
Likasi city to 81.1% in the rural northern district of
Table 1 Outbreak response immunization coverage estimates (%) with 95% confidence interval by age group and study site, 2006-2011
Survey All targeted ages 6 - 8 months 9 - 11 months 12 - 24 months 25 - 59 months 5 - 9 years 10 - 14 years
Country Location Year Target VC % CI 95% VC % CI 95% VC % CI 95% VC % CI 95% VC % CI 95% VC % CI 95% VC % CI 95%
Chad N’Djamena 2005 6-59 m 71.4 [68.9;73.8] 78.6 [63.8;88.4] 69.8 [54.6;81.6] 70.5 [65.2;75.3] 71.4 [68.3;74.4] - -
DRC Matadi 2006 6 m-15 y 97.1 [94.0;98.6] 93.1 [82.7;97.5] 93.7 [81.0;98.1] 95.8 [91.1;98.0] 96.9 [93.3;98.6] 97.5 [93.5;99.1] 98.6 [96.1;99.5]
Mbuji Mayi 2006 6-59 m 94.3 [93.2;95.3] 94.4 [89.4;97.1] 94.3 [91.1;96.4] 93.8 [91.6;95.4] 94.5 [93.4;95.5]
Cameroon Maroua 2009 9 m-15 y 80.3 [76.7;83.5] - 61.3 [51.2;70.5] 77.0 [69.6;83.0] 79.4 [74.5;83.6] 84.7 [80.9;87.8] 79.1 [74.7;82.9]
Chad N’Djamena 2005 6 m-15 y 84.9 [83.2;86.5] 70.1 [60.3;78.4] 78.5 [72.1;83.8] 84.9 [81.7;87.5] 87.8 [85.6;89.7] -
Malawi Blantyre 2010 6 m-15 y 93.1 [90.6;95.0] 90.7 [75.9;96.8] 84.3 [69.8;92.5] 87.9 [81.3;92.4] 92.1 [89.1;94.3] 95.2 [92.3;97.0] 94.0 [89.9;96.5]
Chiradzulu 2010 6 m-15 y 98.0 [97.3;98.5] 91.0 [79.9.96.2] 92.2 [80.8;97.0] 98.2 [95.1;99.4] 97.9 [96.5;98.8] 98.5 [97.6;99.1] 98.0 [96.1;99.0]
Thyolo 2010 6 m-15 y 96.7 [95.6;97.5] 75.3 [61.0;85.6] 84.8 [71.2;92.6] 96.9 [94.3;98.3] 96.6 [94.1;98.1] 98.2 [96.8;99.0] 97.4 [95.8;98.4]
Mangochi 2010 6 m-15 y 96.5 [94.7;97.7] 93.0 [84.6;97.0] 95.2 [88.0;98.2] 95.3 [92.2;97.2] 97.3 [95.4;98.4] 96.7 [94.2;98.1] 96.2 [93.9;97.7]
Lilongwe 2010 6 m-15 y 95.8 [94.2;96.9] 91.5 [80.1;96.7] 88.9 [80.1;94.0] 91.4 [86.5;94.6] 95.2 [92.6;96.9] 97.3 [95.2;98.4] 97.0 [94.8;98.2]
Mzimba 2010 6 m-15 y 92.3 [89.6;94.4] 82.1 [71.9;89.2] 92.5 [84.7;96.5] 95.5 [91.8;97.5] 90.7 [87.9;93.0] 93.9 [90.6;96.0] 92.2 [88.1;94.9]
Balaka – Machinga 2010 6 m-15 y 96.0 [94.1;97.4] 93.7 [85.3;97.5] 96.7 [90.0;99.0] 95.3 [90.5;97.7] 95.8 [92.9;97.6] 97.1 [95.0;98.3] 95.2 [92.2;97.0]
Overall 2010 6 m-15 y 95.5 [94.9;96.1] 86.3 [81.6;89.9] 89.9 [85.8;92.8] 94.3 [92.9;95.5] 95.2 [94.3;96.0] 96.9 [96.2;97.5] 95.9 [95.0;96.7]
DRC Likasi city 2011 6 m-15 y 99.3 [98.9;99.6] 95.7 [88.5;98.5] 99.4 [95.9;99.9] 98.3 [96.3;99.2] 99.3 [98.4;99.7] 99.6 [99.0;99.9] 99.8 [99.2;99.9]
Lubumbashi 2011 6 m-15 y 98.1 [97.3;98.6] 97.6 [92.4;99.3] 96.3 [88.8;98.9] 97.9 [95.9;98.9] 97.9 [96.5;98.7] 98.1 [96.8;98.8] 98.6 [97.6;99.2]
Kapolowe 2011 6 m-15 y 97.0 [88.0;99.3] 100.0 - 93.3 [61.6;99.2] 96.9 [86.6;99.4] 96.9 [85.9;99.4] 96.9 [89.4;99.2] 97.2 [86.9;99.5]
Kambove 2011 6 m-15 y 94.7 [81.8;98.6] 93.7 [63.0;99.2] 97.8 [84.3;99.7] 89.8 [71.3;96.9] 95.1 [76.8;99.1] 96.0 [83.6;99.1] 93.9 [77.2;98.6]
Kasenga 2011 6 m-15 y 93.8 [91.0;95.7] 91.9 [82.8;96.4] 90.3 [74.4;96.8] 91.0 [83.5;95.2] 91.8 [87.2;94.8] 94.7 [91.9;96.5] 96.8 [93.1;98.6]
Malemba-Nkulu 2011 6 m-10y 81.1 [76.5;84.9] 75.1 [61.2;85.2] 78.0 [64.1;87.6] 83.5 [77.0;88.5] 79.9 [74.6;84.2] 82.2 [76.8;86.6] -
Kipushi 2011 6 m-15 y 97.2 [95.7;98.2] 89.6 [70.4;96.9] 93.3 [74.2;98.6] 97.0 [92.9;98.8] 96.7 [94.3;98.1] 98.4 [96.8;99.2] 97.5 [94.7;98.9]
Overall 2011 6 m-15 y 96.7 [95.9;97.4] 95.0 [92.3;96.8] 94.6 [90.9;96.8] 96.0 [94.5;97.2] 96.2 [95.2;97.0] 96.7 [95.7;97.5] 98.2 [97.2;98.9]
Burundi Kirundo 2011 6 m-15 y 96.7 [94.4;98.1] 93.9 [63.7;99;3] 84.7 [55.7;96.1] 93.4 [85.4;97.2] 97.5 [94.1;99.0] 97.3 [94.9;98.6] 97.2 [93.3;98.9]
Chad Moissala (1) 2011 9-59 m 84.3 [75.8;90.2] - 73.5 [59.2;84.1] 84.3 [75.3.90.4] 85.4 [76.5;91.3] - -
Moissala (2) 2011 6 m-15 y 94.0 [83.8;98.0] - 79.7 [62.6;90.2] 94.9 [77.2;99.0] 95.2 [86.8;98.3] - -
Overall 2011 6 m-15 y 86.4 [79.8;91.1] - 74.8 [63.5;83.6] 86.6 [79.5;91.5] 87.5 [80.7;92.2] - -
CAR Kabo 2011 9 m-15 y 92.0 [85.5;95.7] 80.0 [60.5;91.3] 95.4 [85.3;98.7] 92.9 [83.8;97.0] 92.6 [85.4;96.4] 90.3 [82.5;94.9] 93.4 [84.4;97.3]
Batangafo 2011 9 m-15 y 90.0 [88.5;91.3] - 88.7 [78.0;94.6] 89.0 [84.8;92.2] 89.6 [87.3;91.6] 91.4 [89.1;93.3] 88.1 [84.2;91.2]
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among children <1 year-old in the surveys conducted
in N’Djaména (Chad) in 2010, in Maroua (Cameroon)
and in Thyolo district (Malawi). ORI coverage did not
vary by sex.
EPI coverage
The surveys conducted in N’Djaména (Chad) in 2005
showed the lowest estimate with only around one third
of children 12 to 23 months of age receiving MCV
through EPI (Table 2). Burundi had the highest estimates
with vaccination coverage above 90%. EPI coverage was
close to 90% in all districts of Malawi. EPI coverage was
significantly lower among children aged 9 to 11 than
amongst 12-23 months old in Katanga province (DRC)Table 2 Expanded Program for Immunization (EPI) coverage e
11 and 12 to 23 months old, by study site, 2006-2011
Survey EPI est
9 to 11 months
Country Location Year VC % CI 95%
Chad N’Djamena 2005 21.3 [13.5;32.0]
DRC Matadi 2006 79.4 [66.4;88.2]
Mbuji Mayi 2006 50.7 [44.7;56.8]
Cameroon Maroua 2009 65.9 [50.7;78.3]
Chad N’Djamena 2010 30.9 [22.6;40.8]
Malawi Blantyre 2010 37.3 [25.2;51.3]
Chiradzulu 2010 59.6 [44.9;72.8]
Thyolo 2010 51.8 [37.8;65.6]
Mangochi 2010 54.3 [43.7;64.5]
Lilongwe 2010 74.4 [63.4;83.0]
Mzimba 2010 53.6 [43.7;63.3]
Balaka - Machinga 2010 78.3 [64.5;87.7]
Overall 2010 57.7 [52.3;62.9]
DRC Likasi city 2011 58.4 [47.6;68.5]
Lubumbashi city 2011 51.4 [37.8;64.8]
Kapolowe 2011 76.5 [50.1;91.3]
Kambove 2011 74.6 [46.9;90.7]
Kasenga 2011 75.5 [55.3;88.5]
Malemba-Nkulu 2011 61.7 [42.7;77.7]
Kipushi 2011 91.6 [69.5;98.1]
Overall 2011 57.6 [48.4;66.2]
Burundi Kirundo 2011 83.4 [58.4;94.7]
Chad Moissala (1) 2011 54.9 [38.8;70.0]
Moissala (2) 2011 32.8 [23.2;44.3]
Overall 2011 49.1 [37.2;61.2]
CAR Kabo 2011 17.0 [5.6;41.3]
Batangafo 2011 46.2 [33.2;59.7]
VC: Vaccine coverage; 95% CI: 95% confidence interval; DRC: Democratic Republic o(p = 0.01), Malawi (p < 0.001) and Moissala district (Chad)
(p < 0.001).
Surveys conducted in diverse locations of the same coun-
try showed significant differences in Malawi (p < 0.001),
and in DRC (p = 0.005), but not in Moïssala district (Chad)
(p = 0.76). In N’Djaména (Chad) there was a significant
increase in vaccination coverage from 2005 to 2010.
Administrative coverage overestimated survey results in
Chad (N’Djaména 2005 and Moïssala 2011), Cameroon
and several health zones of DRC (Likasi, Kambove,
Kasenga and Malemba-Nkulu). The surveys conducted
in Matadi (DRC), Kirundo (Burundi) and Batangafo (CAR)
showed higher vaccination coverage than administrative
estimates. Administrative coverage best approximated
survey results in Malawi.stimates (%) with 95% confidence interval, children 9 to
imates Administrative coverage
12 to 23 months
VC % CI 95% CV % Area Year
31.3 [27.2;35.7] 48% National 2005
87.7 [81.0;92.2] 71% National 2005
71.4 [67.1;75.3] 67.2% Mbuji-Mayi 2005
66.1 [58.5;73.0] 89% City 2008
68.6 [61.7;74.7 72% National 2009








85.9 [80.9;89.7] 96% to 129% City 2010
76.6 [69.6;82.5] 57% to 153% City 2010
69.0 [55.2;80.1] 73% Health zone 2010
61.9 [46.9;74.9] 90% Health zone 2010
77.6 [69.5;84.0] 103% Health zone 2010
76.1 [68.2;82.4] 90% Health zone 2010
83.8 [74.0;90.3] 78% Health zone 2010
76.4 [72.1;80.2] -
99.1 [93.1;99.9] 88% National 2010
73.5 [64.2;81.0] 87% National 2009
71.6 [61.0;80.2]
73.1 [65.5;79.4]
63.7 [48.1;76.9] 62.5% Batangafo 2010
72.7 [66.4;78.3] 62% National 2009
f Congo; CAR: Central African Republic.
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The surveys conducted in Katanga district in DRC in
2011 showed the highest coverage estimates for SIA
activities (Table 3). Among these, the greatest coverage
was obtained in Lubumbashi city and the lowest in
Kambove, both in DRC. In Malawi, SIA coverage also
varied within the country. Reported SIA administrative
coverage was typically very high and often above 95%.Other mass vaccination campaigns
Surveys results showed that previous ORI conducted by
MoH had the highest coverage estimate in CAR in 2011
with 79.0% [95% CI: 75.7.4-82.0%] in Batangafo and
71.0% [95% CI: 58.4-80.6%] in Kabo (Table 4). Estimated
coverage was <55% in all the other locations and reached a
lowest 26.7% [95% CI: 21.4-32.8%] in Maroua (Cameroon).Table 3 Supplemental Immunization Activities (SIA) coverage
recent SIA before the outbreak response immunization, by st
Survey SIA
Country Location Year Year Target
Chad N’Djamena 2005 - -
DRC Matadi 2006 - -
Mbuji Mayi 2006 2002 6 m - 1
Cameroon Maroua 2009 2006 9 - 59
Chad N’Djamena 2010 - -






Balaka - Machinga 2010
Overall 2010








Burundi Kirundo 2011 2009 9-59
Chad Moissala (1) 2011 2006
Moissala (2) 2011 2006
CAR Kabo 2011 2008
Batangafo 2011 2008
NA: Not assessed; VC: Vaccine coverage; 95% CI: 95% confidence interval; DRC: DemOfficial administrative coverage was unavailable for these
locations at this spatial scale.MCV vaccination in different opportunities
While taking into account the different vaccination
opportunities, a portion of children remained unvac-
cinated. The proportion of unvaccinated children was
highest in N’Djaména in 2005 where 16.8% [95% CI:
15.0%-18.6%] of children remained unvaccinated. This
figure decreased to 5.6% [95% CI: 4.6%-6.7%] in the survey
conducted in 2010. However, the proportion of unvaccin-
ated children was >5% in several sites: Moissala (Chad)
(9.9% [95% CI: 5.7-16.7%]), Kabo (CAR) (8.7% [95% CI:
5.3-13.9%]), Malemba-Nkulu (DRC, 2011) (8.1% [95% CI:
5.6-11.6%]) and in Maroua city (Cameroon) (6.5% [95%
CI: 4.7%-9.0%]).estimates (%) with 95% confidence interval, for the most
udy site, 2006-2011
SIA estimates SIA administrative coverage
pop. VC % CI 95% VC %
- -
- -
5 y 49.5 [42.5;56.5] 96.4
m NA 94
- -





















ocratic Republic of Congo; CAR: Central African Republic.
Table 4 Previous outbreak response immunization coverage estimates (%) with 95% confidence interval, by study site,
2006-2011
Survey Previous ORI Coverage estimates
Country Location Year Year Target population VC % CI 95%
Cameroon Maroua 2009 2008 9 - 59 m 26.7 [21.4;32.8]
Chad N’Djamena 2010 2009 53.2 [51.0;55.3]
Malawi Blantyre 2010 2010 9 - 59 m 42.5 [34.4;51.2]
Chiradzulu 2010 - -
Thyolo 2010 - -
Mangochi 2010 - -
Lilongwe 2010 2010 9 - 59 m 34.0 [22.4;47.8]
Mzimba 2010 2010 9 - 59 m 29.4 [22.5;37.4]
Balaka - Machinga 2010 - -
CAR Kabo 2011 2011 9-47 m 71.0 [59.4;80.4]
Batangafo 2011 2011 9-47 m 79.0 [75.7;82.0]
VC: Vaccine coverage; 95% CI: 95% confidence interval; CAR: Central African Republic.
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living in N’Djamena in 2005 had only received one dose
of MCV (75.4% [95% CI: 73.4-77.3%]). This proportion
was around one-third in Moïssala (Chad) (32.2% [95%
CI: 25.9-39.2%]) and Maraoua (Cameroon) (31.9% [95%
CI: 28.3-35.9%]) and between one-quarter and one-
third in Kabo (29.7% [95% CI: 21.2-39.8%]), Batangafo
(28.4% [95% CI: 26.2-30.8%]), and Mbuji-Mayi 27.3%
[95% CI: 24.9-29.9%].
The surveys conducted in Malawi in 2010 and in DRC
in 2011 where children had previous vaccination oppor-
tunities through EPI and SIA showed that ORI provided
the first MCV dose to approximately 90% of children 6
to 8 months old. Among children in the EPI target group
(9 to 11 months), approximately one-third received their
first dose of MCV during the ORI and half received their
second dose. The highest estimate for the second dose of
MCV during ORI for children 9 to 11 months old was in
Malawi with 55.8% [95% CI: 50.1-61.3%]. The majority of
children older than 1 year but too young to be eligible for
the last SIA received a second dose during the ORI. This
was 78.0% of the children [95% CI: 75.4-80.4%] in Katanga
province (DRC) and up to 90.9% [95% CI: 89.3-92.2%] in
Malawi.
In these contexts, over half of the children eligible for
the last SIA received a third dose of MCV. This was
55.8% [95% CI: 53.5-58.2% in the surveys conducted in
Katanga province (DRC) and 63.4% [95% CI: 59.7-66.9%]
in the surveys conducted in Malawi.
However, the proportion of children vaccinated during
ORI was significantly higher among children who previ-
ously received at least one dose of MCV (Malawi and
Katanga province, p < 0.001). This is best illustrated in
the rural northern zone of Katanga Province (DRC) where
52.3% [95% CI:42.6%;61.9%] of children never vaccinatedbefore the ORI, 89.9% [95% CI:86.0%;92.7%] of children
who received 1 dose of MCV prior to the ORI and 91.1%
[95% CI:86.8%;94.1%] of those who received 2 doses prior
to the ORI were vaccinated during the campaign.
Discussion
We present the results of 24 population-based measles vac-
cination coverage surveys conducted in between 2005 and
2011 in 28 locations in Sub-Saharan Africa. In 2008, the
WHO African Region measles technical advisory group
recommended establishing a measles pre-elimination
goal, to be achieved by the end of 2012, with the following
immunization targets: >90% national MCV routine cover-
age, with at least 80% coverage in all districts; and ≥95%
SIA coverage in all districts [11]. Routine vaccination
coverage reached high levels in several districts of Malawi
and in Kirundu (Burundi), but most of the surveys showed
insufficient EPI coverage.
Survey results showed that the highest vaccination cov-
erage was obtained through ORI. For most infants 6 to 8
months of age, ORI provided the first MCV vaccination.
These infants are at higher risk of complications and death
in case of illness highlighting the effectiveness of vaccinat-
ing this population in ORI.
EPI coverage appeared to be lower among children
aged 9 to 11 months than 12 to 23 months old. This might
show a delay in the age of routine vaccination. The recom-
mendation to enlarge the targeted age group for routine
activities [12] should be encouraged and reinforced. This
would allow the protection of children that missed the
routine age window and slow the build-up of susceptible
children contributing to the risk of an epidemic in areas
with circulating virus. While EPI programs should be flex-
ible to ensure vaccination, efforts are needed to ensure an
early first dose administration as a first priority.
Grout et al. BMC Public Health 2014, 14:193 Page 8 of 9
http://www.biomedcentral.com/1471-2458/14/193In contexts where SIAs were implemented, coverage
was low and far under the targeted 95%. Moreover, in
many locations these activities were not implemented or
often implemented late, without respecting the recom-
mended interval between SIAs. For instance, in Katanga
province, after the 2007 SIA few measles cases were
reported. The next SIA was planned in 2010, but this
was postponed [13] contributing to the causes of a
large outbreak in 2010-2011 [14].
Often administrative coverage was higher than survey
results. This was most significant for SIA, where all ad-
ministrative estimates were higher than surveys results.
Administrative estimates are often at national level and
do not account for provincial or district differences.
Population-based surveys can provide specific information
on coverage and help target interventions. A model that
considers both administrative and survey data has even
been developed to characterize the performance of the
activities leading to the estimated coverage and help to
predict the effect of future vaccination activities [15].
This kind of exercise is very important to adequately
assess the risk of outbreaks.
Despite several opportunities, a non-negligible proportion
of children remained unvaccinated or had not received the
recommended 2 doses. Conversely, for some children ORI
provided the third or higher dose. Moreover, children not
reached either by EPI program or by SIA were also less
reached by ORI. These results highlight that children
are not equally reached by vaccination activities and
multiplying vaccine opportunities does not always imply
that unvaccinated children are reached. Further work is
needed to ensure that immunization activities reach
unprotected children. And in case of limited resources,
previous MCV vaccination activities and their coverage
should be evaluated to better allocate resources and
improve coverage.
These survey data are subject to limitations. First, sur-
veys were conducted only in settings were measles con-
trol strategies were not efficient enough to avoid an
outbreak, but where surveillance system detected an in-
crease in measles cases. Vaccine coverage in these areas
is likely to be different from places where no outbreak
occurred or was detected during the last decade.
Second, although card confirmation is the preferred
method for ascertaining coverage, this is not always pos-
sible and oral history is considered. For example, none
of the children could show a vaccination card for SIA,
and only an average of 16.9% of the children considered
as vaccinated through EPI could show their vaccination
card [range 1.8% - 36.2%]. Vaccination status regarding
ORI was better documented as half of the children con-
sidered as vaccinated could show their vaccination card
[range: 0.0% - 83.4%]. This proportion was generally
high, except in Malawi and Maroua where quasi none ofthe vaccination status was confirmed by card. As a result,
over-reporting or under-reporting of vaccination might
have occurred, depending on the context and despite
probing questions. However, previous studies in areas of
high measles incidence have shown parental recall to be
reliable [16].
Third, most of the surveys were conducted within a
month after the end of ORIs. There is therefore low risk
of recall bias for ORI coverage estimates, especially as
there is less risk of card loss. Information on routine vac-
cination was collected for all age groups, i.e. for children up
to 15 years of age. Recall bias, especially for older children
for which vaccination in routine vaccination occurred long
ago, might be expected. We therefore chose not to present
EPI coverage for older age group but this likely resulted in
an overestimation of the number of doses received in older
age groups.
Finally, although standardized protocols and training
of all surveyors was rigorously implemented across set-
tings, there may be additional inaccuracies in the data
related to individual interviewers and supervisors as well
as the inaccuracies of population data used to select the
samples.
It is also important to recognize that although popula-
tion surveys are a rapid means to obtain a vaccine cover-
age estimate, without serological confirmation, estimates
of coverage remain an inference.Conclusion
Population-based surveys are important to have reliable
estimates of MCV coverage and can serve as a tool to
assess different vaccine opportunities and to have a
better understanding of coverage variations among age
group and settings. Control pre-elimination targets
were still not reached in the studied sites and might
explain the occurrence of repeated measles outbreak
in Sub-Saharan African countries. Furthermore, despite
different vaccine opportunities, the number of unvaccin-
ated or not fully vaccinated children was high in some
settings. Strategies to better target hard-to-reach children
are needed.Additional file
Additional file 1: Table S1. Design, sample size and vaccination
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